NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 08327-0309-09 — Silver topical gel, extended releaseAI (71 hospitals, 29,793–30,612 samples)
• NDC 00078-0813-01 — Tobramycin eye ointmentAI (579 hospitals, 29,593–30,610 samples)
• NDC 00168-0268-15 — Betamethasone topical ointment 0.05%AI (153 hospitals, 29,737–30,610 samples)
• NDC 47781-0427-47 — Fentanyl 75 mcg/hr skin patchAI (517 hospitals, 29,709–30,609 samples)
• NDC 60687-0681-01 — Folic acid 1 mg tabletAI (530 hospitals, 29,462–30,605 samples)
• NDC 68084-0536-01 — Clopidogrel 75 mg oral tabletsAI (688 hospitals, 29,458–30,601 samples)
• NDC 63323-0488-07 — Lidocaine with epinephrine injectionAI (203 hospitals, 28,572–30,597 samples)
• NDC 00409-3796-01 — Ketorolac tromethamine 60 mg/2 mL intramuscular injectionAI (390 hospitals, 28,240–30,589 samples)
• NDC 65862-0503-20 — Amoxicillin-clavulanate 875/125 mg tabletAI (762 hospitals, 29,232–30,573 samples)
• NDC 68462-0406-01 — Indomethacin 25 mg capsulesAI (733 hospitals, 29,855–30,566 samples)
• NDC 00409-1966-01 — Bacteriostatic sodium chloride (saline) injection solutionAI (107 hospitals, 30,296–30,557 samples)
• NDC 00168-0033-15 — BETAMETHASONE VALERATE 0.1 % TOPICAL OINTMENTAI (272 hospitals, 29,574–30,555 samples)
• NDC 00832-7123-01 — Divalproex 250 mg delayed-release tabletAI (267 hospitals, 29,780–30,554 samples)
• NDC 47781-0423-47 — Fentanyl 12 mcg/hr skin patchAI (435 hospitals, 29,623–30,550 samples)
• NDC 68094-0764-59 — Midazolam oral syrup 2 mg/mLAI (485 hospitals, 30,073–30,550 samples)
• NDC 00264-1510-32 — Dextrose 5% intravenous solutionAI (506 hospitals, 28,441–30,538 samples)
• NDC 69097-0846-07 — Cyclobenzaprine 10 mg tabletsAI (559 hospitals, 29,574–30,537 samples)
• NDC 00591-3508-54 — Clonidine 0.1 mg/24-hour skin patchAI (319 hospitals, 29,645–30,536 samples)
• NDC 11980-0211-05 — Fluorometholone 0.1% eye drop suspensionAI (341 hospitals, 29,714–30,524 samples)
• NDC 00143-9983-03 — Cefazolin sodium 10 g injectionAI (412 hospitals, 25,401–30,522 samples)
• NDC 00832-1120-89 — Testosterone 1% transdermal gel packetAI (74 hospitals, 29,476–30,520 samples)
• NDC 68180-0121-01 — Cephalexin 250 mg capsulesAI (301 hospitals, 29,710–30,520 samples)
• NDC 47781-0424-11 — Fentanyl 25 mcg/hr 72-hour patchAI (403 hospitals, 29,570–30,515 samples)
• NDC 00641-6195-01 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (87 hospitals, 29,273–30,515 samples)
• NDC 00904-5854-61 — Ibuprofen 600 mg tabletsAI (749 hospitals, 29,776–30,514 samples)
• NDC 59762-0131-02 — Silver sulfadiazine 1% topical creamAI (171 hospitals, 29,396–30,512 samples)
• NDC 00409-7335-03 — Ceftriaxone sodium injection 2 gramAI (786 hospitals, 23,588–30,509 samples)
• NDC 62332-0606-60 — Nystatin and triamcinolone topical creamAI (42 hospitals, 29,553–30,507 samples)
• NDC 61314-0237-10 — Cromolyn 4% eye drops, 10 mL bottleAI (358 hospitals, 29,550–30,504 samples)
• NDC 00591-3216-17 — Testosterone 1% transdermal gel packetAI (96 hospitals, 29,549–30,494 samples)
• NDC 63323-0185-20 — Sterile water for injectionAI (368 hospitals, 30,196–30,484 samples)
• NDC 00378-0873-16 — Clonidine 0.3 mg weekly skin patchAI (373 hospitals, 29,581–30,481 samples)
• NDC 45802-0598-00 — Sumatriptan 20 mg nasal sprayAI (83 hospitals, 29,577–30,477 samples)
• NDC 00517-7604-01 — Acetylcysteine 20% inhalation solutionAI (453 hospitals, 29,547–30,474 samples)
• NDC 63323-0623-74 — Sodium chloride 0.9% saline solution, 250 mL bagAI (206 hospitals, 29,012–30,470 samples)
• NDC 66993-0002-10 — Estradiol 0.1 mg/g vaginal creamAI (437 hospitals, 29,587–30,460 samples)
• NDC 63323-0411-15 — Midazolam 1 mg/mL injectionAI (313 hospitals, 26,023–30,451 samples)
• NDC 00713-0686-15 — Nystatin ointment 100,000 units per gramAI (277 hospitals, 29,487–30,450 samples)
• NDC 69374-0925-10 — Epinephrine 1 mg/10 mL syringeAI (348 hospitals, 29,359–30,448 samples)
• NDC 72578-0002-01 — Acyclovir 200 mg capsulesAI (526 hospitals, 29,655–30,447 samples)
• NDC 51754-0103-01 — Cupric chloride intravenous solutionAI (165 hospitals, 29,544–30,444 samples)
• NDC 00591-3216-30 — Testosterone 1% transdermal gel packetAI (104 hospitals, 29,544–30,444 samples)
• NDC 00781-7309-58 — Rivastigmine 9.5 mg/24-hour transdermal patchAI (241 hospitals, 29,544–30,444 samples)
• NDC 00409-2053-20 — KETAMINE 50 MG/ML INJECTION SOLUTIONAI (54 hospitals, 29,544–30,444 samples)
• NDC 25021-0106-10 — Ceftriaxone sodium 1 gram injection vialAI (585 hospitals, 19,544–30,443 samples)
• NDC 76045-0001-20 — Midazolam injection, 2 mg syringeAI (227 hospitals, 27,939–30,441 samples)
• NDC 60505-0815-00 — Desmopressin acetate nasal sprayAI (739 hospitals, 29,492–30,437 samples)
• NDC 62332-0582-31 — Lidocaine-prilocaine topical creamAI (204 hospitals, 29,477–30,431 samples)
• NDC 00409-9558-31 — Rocuronium injection (10 mg/mL)AI (162 hospitals, 29,423–30,422 samples)
• NDC 60687-0394-83 — Ipratropium bromide 0.02% inhalation solutionAI (554 hospitals, 29,043–30,420 samples)